Put Options

31 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $18.4 Million - $21.3 Million
165,100 Added 655.16%
190,300 $21.6 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $10.1 Million - $10.8 Million
-81,600 Reduced 76.4%
25,200 $3.12 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $10.6 Million - $12.4 Million
-93,800 Reduced 46.76%
106,800 $14.1 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $10.2 Million - $11.1 Million
-102,000 Reduced 33.71%
200,600 $21.9 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $29.8 Million - $33.1 Million
-289,100 Reduced 48.86%
302,600 $31.2 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $51.5 Million - $56.1 Million
474,300 Added 404.0%
591,700 $68.3 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $4.21 Million - $4.7 Million
-40,900 Reduced 25.84%
117,400 $12.5 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $26 Million - $33.3 Million
-296,800 Reduced 65.22%
158,300 $17.6 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $11.3 Million - $12.7 Million
134,100 Added 41.78%
455,100 $39.2 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $4.98 Million - $5.64 Million
59,600 Added 22.8%
321,000 $29.3 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $8.23 Million - $9.22 Million
-111,900 Reduced 29.98%
261,400 $98.2 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $15 Million - $18.9 Million
-208,200 Reduced 35.8%
373,300 $28.6 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $41.7 Million - $45.8 Million
581,500 New
581,500 $43.7 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $48.1 Million - $52.9 Million
-671,600 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $16.4 Million - $18.1 Million
233,100 Added 53.16%
671,600 $52.2 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $73.4 Million - $86.4 Million
-1,065,400 Reduced 70.84%
438,500 $33.8 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $108 Million - $120 Million
1,503,900 New
1,503,900 $123 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $127 Million - $140 Million
-1,763,900 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $30.2 Million - $34.2 Million
412,700 Added 30.54%
1,763,900 $146 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $2.67 Million - $3.04 Million
37,900 Added 2.89%
1,351,200 $104 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $84.4 Million - $117 Million
-1,331,300 Reduced 50.34%
1,313,300 $101 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $166 Million - $187 Million
2,133,300 Added 417.23%
2,644,600 $241 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $7.3 Million - $7.95 Million
95,900 Added 23.09%
511,300 $41.1 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $7.69 Million - $8.98 Million
-110,100 Reduced 20.95%
415,400 $34.8 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $4.79 Million - $5.47 Million
-68,900 Reduced 11.59%
525,500 $43.7 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $25.2 Million - $29.3 Million
386,900 Added 186.46%
594,400 $45.4 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $5.15 Million - $6.05 Million
89,200 Added 75.4%
207,500 $14.7 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $6.69 Million - $7.87 Million
-131,700 Reduced 52.68%
118,300 $7.18 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $29.4 Million - $34.2 Million
-577,900 Reduced 69.8%
250,000 $13.6 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $30.1 Million - $36 Million
584,000 Added 239.44%
827,900 $46.6 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $14.3 Million - $15.4 Million
243,900
243,900 $15.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.